Search

everythinglearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

DA-9401 helps protect rat testis from finasteride damage.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Finasteride exposure harms tadpole reproduction and hormone balance.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

COVID-19 may harm male fertility and damage the reproductive system.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Finasteride helps brain function in rats with liver-related brain issues.

Early balding at 40 increases prostate cancer risk.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The document concludes that more research is needed to fully understand the causes of PCOS.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.

Laser-assisted drug delivery improves hair loss.